Michael J Ackerman, MD | |
200 1st St Sw, Rochester, MN 55905-0001 | |
(507) 284-2511 | |
Not Available |
Full Name | Michael J Ackerman |
---|---|
Gender | Male |
Speciality | Pediatric Medicine |
Experience | 29 Years |
Location | 200 1st St Sw, Rochester, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104802032 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | ME147751 (Florida) | Secondary |
2080P0202X | Pediatrics - Pediatric Cardiology | 39291 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mayo Clinic Hospital Rochester | Rochester, MN | Hospital |
Mayo Clinic Florida | Jacksonville, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic | 6507778255 | 4232 |
Mayo Clinic - Florida | 5698689297 | 1310 |
News Archive
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Yesterday, the Medicare Payment Advisory Commission (MedPAC) reviewed draft recommendations related to the flawed and unsustainable Medicare Physician Payment system. The American College of Surgeons (ACS) is pleased that the MedPAC has recognized the need to eliminate the Sustainable Growth Rate (SGR) and move towards a reimbursement system that is based on quality of care.
› Verified 9 days ago
Entity Name | Mayo Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922074434 PECOS PAC ID: 6507778255 Enrollment ID: O20031103000285 |
News Archive
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Yesterday, the Medicare Payment Advisory Commission (MedPAC) reviewed draft recommendations related to the flawed and unsustainable Medicare Physician Payment system. The American College of Surgeons (ACS) is pleased that the MedPAC has recognized the need to eliminate the Sustainable Growth Rate (SGR) and move towards a reimbursement system that is based on quality of care.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Michael J Ackerman, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 | Michael J Ackerman, MD 200 1st St Sw, Rochester, MN 55905-0001 Ph: (507) 284-2511 |
News Archive
Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.
The effectiveness of cancer vaccines could be dramatically boosted by first loading the cancer antigens into silicon microparticles, report scientists from Houston Methodist and two other institutions in an upcoming Cell Reports (early online).
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Yesterday, the Medicare Payment Advisory Commission (MedPAC) reviewed draft recommendations related to the flawed and unsustainable Medicare Physician Payment system. The American College of Surgeons (ACS) is pleased that the MedPAC has recognized the need to eliminate the Sustainable Growth Rate (SGR) and move towards a reimbursement system that is based on quality of care.
› Verified 9 days ago
Alejandra Catalina Vasquez Avila, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Patricia S Simmons, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Mrs. Asmaa Ferdjallah, MD, MPH Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Dr. Mats Steffi Jennifer Masilamani, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Valeria Cristiani, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Flora Robinson Howie, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 | |
Meredith Mary Renda, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 200 1st St Sw, Rochester, MN 55905 Phone: 507-284-2511 |